University Health Network and Boehringer Ingelheim Canada partner to impact patients lives and help a healthcare system under strain
The Ontario healthcare system is under strain, still recovering from the demands of the COVID-19 pandemic. The University Health Network (UHN) and Boehringer Ingelheim (Canada) Ltd. have partnered to address a critical need of heart failure patients.
The objective of the partnership is to expand patient reach of UHN’s successful Medly Program— an innovative, digital therapeutic solution that delivers the benefits of specialized clinical heart failure management at home while improving quality of life and reducing hospitalizations.